[Diagnosis and therapeutics of 24 cases of pulmonary sclerosing hemangioma].
Pulmonary sclerosing hemangioma (PSH) is an uncommon benign lung tumor. The study was to investigate the clinical features, diagnosis, treatment, and prognosis of PSH in order to promote the recognition of this disease. Data of 24 pathologically confirmed PSH patients treated in Sun Yat-sen University Cancer Center from Jan. 1999 to Jul. 2007 were reviewed. The clinical features, diagnosis, treatment, and prognosis were summarized. Of the 24 patients, two (8.3%) were males, and 22 (91.7%) were females. The median age of the patients was 54.5 years old, ranging from 21 to 76 years old. Ten (41.7%) patients were detected upon routine medical examination, while 14 (58.3%) patients presented clinical symptoms, including cough, hemoptysis, chest pain, chest distress and tachypnea. The imaging examination revealed isolated round or similar round nodules with distinct margins and homogeneous density. No calcification and aerial semilunar sign appeared. All the patients received surgical resection without complications and mortality. Eight patients underwent lobectomy, 13 underwent wedge resection, two underwent tumor resection and one underwent segmentectomy. There was no recurrence or metastasis during follow-ups. Clinical and radiological characteristics of PSH are nonspecific. Thus, accurate diagnosis of PSH before operation is difficult. Confirmation of PSH depends on pathological examination. Surgical resection is an effective treatment for PSH, among which lobectomy or limited resection is advisable, while systematic lymph node dissection is not recommended.